2013
DOI: 10.1002/biof.1130
|View full text |Cite
|
Sign up to set email alerts
|

Why it is necessary to translate curcumin into clinical practice for the prevention and treatment of metabolic syndrome?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
37
0

Year Published

2013
2013
2019
2019

Publication Types

Select...
8

Relationship

6
2

Authors

Journals

citations
Cited by 31 publications
(37 citation statements)
references
References 0 publications
0
37
0
Order By: Relevance
“…Curcumin has documented anti‐inflammatory [Esmaily et al, ; Panahi et al, ], antioxidant [Panahi et al, ; Sahebkar et al, , ; Panahi et al, ] and immunomodulatory [Ganjali et al, ; Panahi et al, , , d; Derosa et al, ; Ghandadi and Sahebkar, ; Karimian et al, ; Mohammadi et al, ; Sahebkar et al, ] activities, and has been found to exert a number of pharmacological therapeutic benefits in a variety of human diseases. Diseases in which curcumin has been shown to produce positive health benefits include osteoarthritis [Panahi et al, ; Sahebkar and Henrotin, ], cancer [Abbas Momtazi and Sahebkar, ; Mirzaei et al, ; Sahebkar, ; Teymouri et al, ], dyslipidemia [Mohammadi et al, ; Panahi et al, ; Sahebkar, , ; Ganjali et al, ], the metabolic syndrome [Sahebkar, ], hyperuricemia [Panahi et al, ], non‐alcoholic fatty liver disease [Rahmani et al, ; Zabihi et al, ], anxiety and depression [Esmaily et al, ; Panahi et al, ], ischemia/reperfusion injury [Sahebkar, ], diabetes [Nabavi et al, ], pulmonary disorders [Panahi et al, , ; Lelli et al, ], and dermatological disturbances [Panahi et al, ]. This wide range of pharmacological effects has been proposed to be due to the numerous molecular targets of curcumin (Table ).…”
Section: Curcumin: Source Structure and Therapeutic Effectsmentioning
confidence: 99%
“…Curcumin has documented anti‐inflammatory [Esmaily et al, ; Panahi et al, ], antioxidant [Panahi et al, ; Sahebkar et al, , ; Panahi et al, ] and immunomodulatory [Ganjali et al, ; Panahi et al, , , d; Derosa et al, ; Ghandadi and Sahebkar, ; Karimian et al, ; Mohammadi et al, ; Sahebkar et al, ] activities, and has been found to exert a number of pharmacological therapeutic benefits in a variety of human diseases. Diseases in which curcumin has been shown to produce positive health benefits include osteoarthritis [Panahi et al, ; Sahebkar and Henrotin, ], cancer [Abbas Momtazi and Sahebkar, ; Mirzaei et al, ; Sahebkar, ; Teymouri et al, ], dyslipidemia [Mohammadi et al, ; Panahi et al, ; Sahebkar, , ; Ganjali et al, ], the metabolic syndrome [Sahebkar, ], hyperuricemia [Panahi et al, ], non‐alcoholic fatty liver disease [Rahmani et al, ; Zabihi et al, ], anxiety and depression [Esmaily et al, ; Panahi et al, ], ischemia/reperfusion injury [Sahebkar, ], diabetes [Nabavi et al, ], pulmonary disorders [Panahi et al, , ; Lelli et al, ], and dermatological disturbances [Panahi et al, ]. This wide range of pharmacological effects has been proposed to be due to the numerous molecular targets of curcumin (Table ).…”
Section: Curcumin: Source Structure and Therapeutic Effectsmentioning
confidence: 99%
“…There is a strong pile of evidence indicating diverse biological activities and health benefits of plant phytochemicals, in particular phenolics and flavonoids (Hodgson and Croft, ; Sahebkar, , , Hu et al ., ; Xiao et al ., ; Huang et al ., ; Ikemura et al ., ; Mohammadi et al ., ; Panahi et al ., , b; Sahebkar, , ; Shin et al ., ). Large‐scale prospective cohorts have suggested an inverse association between consumption of fruits and vegetables rich in flavonoids and CVD mortality (Liu et al ., ; Mink et al ., ).…”
Section: Introductionmentioning
confidence: 99%
“…Curcuminoids constitute about 5% of turmeric composition and comprise curcumin (65–80%; also referred to as curcumin I), demethoxycurcumin (15–25%; curcumin II), and bisdemethoxycurcumin (5–15%; curcumin III). Curcuminoids possess several medicinal properties, and their efficacy has been confirmed against a wide array of diseases (Ganjali et al ., ; Gupta et al ., , ; Iranshahi et al ., ; Panahi et al ., ; Sahebkar, , , , , ; Shehzad et al ., , ) 9. Most of the pharmacological properties of curcuminoids are due to their potent antiinflammatory (Panahi et al ., ; Shehzad et al ., ) and antioxidant (Ak and Gulcin, ; Panahi et al ., ; Sahebkar et al ., ) effects.…”
Section: Introductionmentioning
confidence: 99%